tiprankstipranks
Ligand Pharma (LGND)
NASDAQ:LGND
US Market
LGND
Ligand Pharma
RESEARCH TOOLSreports
Want to see LGND full AI Analyst Report?

Ligand Pharma (LGND) Income Statement

842 Followers

Ligand Pharma Income Statement

Last quarter (Q1 2026), Ligand Pharma's total revenue was $51.72M, an increase of 14.09% from the same quarter last year. In Q1, Ligand Pharma's net income was $-13.35M. See Ligand Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 268.09M$ 167.13M$ 131.31M$ 196.25M$ 241.54M
Gross Profit
$ 261.50M$ 156.06M$ 96.27M$ 143.42M$ 179.37M
Operating Expenses
$ 214.30M$ 178.66M$ 84.32M$ 140.38M$ 75.52M
Depreciation and Amortization
$ 33.77M$ 35.24M$ 36.52M$ 43.39M$ 50.95M
EBITDA
$ 192.74M$ 40.79M$ 100.84M$ 81.20M$ 142.77M
Operating Income
$ 47.20M$ -22.61M$ 11.94M$ 3.04M$ 103.85M
Other Income/Expenses
$ 111.76M$ 25.12M$ 51.72M$ 32.97M$ -31.65M
Pretax Income
$ 158.96M$ 2.52M$ 63.66M$ 36.01M$ 72.20M
Net Income
$ 124.45M$ -4.03M$ 52.15M$ -33.36M$ 57.14M
Per Share Metrics
Basic EPS
$ 6.44$ -0.22$ 3.02$ -1.98$ 3.46
Diluted EPS
$ 6.13$ -0.22$ 2.94$ -1.98$ 3.34
Weighted Average Shares Outstanding
 19.34M 18.29M 17.30M 16.87M 16.63M
Weighted Average Shares Outstanding (Diluted)
 20.29M 18.29M 17.76M 16.87M 17.25M
Currency in USD

Ligand Pharma Earnings and Revenue History